Angiotensin converting enzyme inhibitors or angiotensin antagonists in diabetic nephropathy

Marcin Grabowski; Krzysztof J. Filipiak; Grzegorz Opolski

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

9/2005
vol. 8

Send email

Copy url:

abstract:

Angiotensin converting enzyme inhibitors or angiotensin antagonists in diabetic nephropathy

Marcin Grabowski

,

Krzysztof J. Filipiak

,

Grzegorz Opolski

Przew Lek 2005; 9: 88-92

Online publish date: 2005/11/22

View full text Get citation

Diabetic nephropathy occurs is the single leading cause of end-stage renal disease. Intensive diabetes management has been shown in large prospective randomized studies to delay the onset of microalbuminuria and the progression of micro- to macroalbuminuria. In the treatment of both micro- and macroalbuminuria, either angiotensin converting enzyme inhibitors or angiotensin II antagonist should be used except during pregnancy.

keywords:

Angiotensin converting enzyme inhibitors or angiotensin antagonists in diabetic nephropathy

Marcin Grabowski , Krzysztof J. Filipiak , Grzegorz Opolski

angiotensin converting enzyme inhibitors, angiotensin II antagonist, diabetic nephropathy

Marcin Grabowski

,

Krzysztof J. Filipiak

,

Grzegorz Opolski